Prostate cancer: Genetic testing and PARP inhibitors in prostate cancer

December 06, 2023 00:31:03
Prostate cancer: Genetic testing and PARP inhibitors in prostate cancer
COR2ED - Oncology Medical Conversation
Prostate cancer: Genetic testing and PARP inhibitors in prostate cancer

Dec 06 2023 | 00:31:03

/

Show Notes

COR2ED Medical Education: Joanne Chien, Nurse Practitioner specialising in urologic cancers at Stanford Health Care in Palo Alto, California, and Dr Alexander Wyatt, Assistant Professor in genitourinary cancer genomics at the Vancouver Prostate Centre, Department of Urologic Sciences at the University of British Columbia, discuss ‘Genetic testing and PARP inhibitors in prostate canceras part of the GU NURSES CONNECT podcast series covering ‘PARP inhibitors in prostate cancer’.

In this podcast, the experts discuss the gene alterations in prostate cancer and why we should consider genetic testing when thinking about treatment options such as PARP inhibitors (PARPi’s). The discussion covers why genetic testing should be performed, who should undergo testing, how to test and what this means in relation to treatment with PARP inhibitors. Dr. Alex Wyatt explains the difference between germline and somatic mutations and Joanne Chien discusses the role of the nurse during genetic counselling discussions and how this role may evolve in the future. Finally, the ongoing trials of PARP inhibitors in combination with other prostate cancer treatments are also considered and whether the outcome of these trials is likely to impact the need to perform genetic testing.

Other Episodes

Episode

December 06, 2023 00:29:42
Episode Cover

HCC: The role of immunotherapy beyond advanced HCC

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced...

Listen

Episode

February 17, 2025 00:11:28
Episode Cover

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions   Key clinical takeaways:   MMR status should be tested in all patients at diagnosis and...

Listen

Episode

December 06, 2023 00:24:55
Episode Cover

Precision oncology: An introduction to molecular testing

This podcast episode provides an introduction to molecular testing in the diagnosis and treatment of cancer.  Prof. David Hong from MD Anderson Cancer Center,...

Listen